SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-186707
Filing Date
2014-05-07
Accepted
2014-05-07 11:32:37
Documents
3
Period of Report
2014-05-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d722313d8k.htm 8-K 18534
2 EX-3.1 d722313dex31.htm EX-3.1 6567
3 EX-3.2 d722313dex32.htm EX-3.2 5068
  Complete submission text file 0001193125-14-186707.txt   31312
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 14819575
SIC: 2836 Biological Products, (No Diagnostic Substances)